Press release
Tendinopathy Market Size in the 7MM is Project to Grow with a Significant CAGR by 2034, estimates DelveInsight
Discover Key Insights into the Tendinopathy Market with DelveInsight's In-Depth Report @ Tendinopathy Market Size [https://www.delveinsight.com/sample-request/tendinopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Tendonitis Market Research Report
* On January 08, 2026- Laboratorios Silanes S.A. de C.V. initiated a Phase III, multicenter, prospective, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of a fixed-dose combination of etoricoxib/betamethasone compared with etoricoxib alone in patients with an acute episode of bursitis, tendinitis, or synovitis affecting the shoulder, elbow, knee, or ankle.
* The Incident cases of Tendinopathy are on the rise, and it is estimated that the United States accounted for more than ~12,000,000 cases in 2023.
* Among gender-specific tendinopathy incident cases, males are the primary contributors compared to females in the United States.
* According to estimates, tendinitis and tendinosis are the primary types of tendinopathy, with tendinosis accounting for the highest number of cases in 2023.
* As per the estimates, in the United States, the treated cases of tendinopathy were ~6,000,000 cases in 2023 which is expected to increase during the forecast period.
* The leading Tendonitis Companies such as MiMedex Group Inc, MEDRx USA Inc, Cerimon Pharmaceuticals, InGeneron Inc, ZetrOZ Inc, ZARS Pharma Inc, Smith & Nephew Inc ., and others.
* Promising Tendonitis Pipeline Therapies such as TENDAXION, TENDOFIT, ZEPTIDE, TENACTIVE/TENDOACTIVE, TENDOMAC, RITISAL , and others.
Discover which therapies are expected to grab the Tendinopathy market share @ Tendinopathy Treatment Market [https://www.delveinsight.com/sample-request/tendinopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Tendinopathy Epidemiology Segmentation in the 7MM
* Total Tendonitis Incident Cases
* Tendonitis Type-specific Incident Cases
* Total Tendonitis Treated Cases
* Tendonitis Region-specific Incident Cases
* Tendonitis Gender-specific Incident Cases
Download the report to understand which factors are driving Tendinopathy epidemiology trends @ Tendinopathy Prevalence [https://www.delveinsight.com/sample-request/tendinopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Tendinopathy Emerging Drugs
* CWT-001: Causeway Therapeutics
TenoMiR(CWT-001), is a microRNA replacement therapy that directly targets critical disease pathways restoring tendons to normal structure and function. We have shown that a single local injection of TenoMiR improves tendon healing in pre-clinical models. TenoMiR is unique in directly targeting the critical collagen production changes associated with tendinopathy. Unlike other therapies, TenoMiR has a well-defined mode of action that is supported by a wealth of scientific data. Moreover, treatment with TenoMiR does not require invasive biopsies and can be delivered at the point of initial diagnosis, initiating recovery at the very earliest time.
* COSENTYX (Secukinumab): Novartis
COSENTYX is a fully human biologic that specifically targets and blocks interleukin-17A (IL-17A), an important cytokine involved in the inflammation of psoriatic arthritis (PsA), moderate to severe plaque psoriasis, ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA). COSENTYX is a proven medicine and has been studied clinically for more than 14 years. Currently, the drug is being investigated in Phase III for the rotator cuff tendinopathy. The company is expected to release data from its Phase III trial (NCT05722522) by 2025.
Tendinopathy Market Insights
Tendinopathy describes a complex, multifaceted pathology of the tendon, characterized by pain, a decline in function, and reduced exercise tolerance. The most common overuse tendinopathies involve the rotator cuff tendon, medial and lateral elbow epicondyles, patellar tendon, gluteal tendons, and the Achilles tendon. The prominent histological and molecular features of tendinopathy include disorganization of collagen fibers, increased microvasculature and sensory nerve innervation, dysregulated extracellular matrix homeostasis, increased immune cells and inflammatory mediators, and enhanced cellular apoptosis.
Tendinopathy Treatment Market Landscape
The Tendinopathy treatment landscape continues to evolve, and several companies are furiously working toward the development of new treatments. Approximately 40-50% patients undergo physiotherapeutic management. In recent years, nutraceutical products are multiplying that seem to favor the healing processes of tendon injuries and are likely to play a role as prevention tools. The preclinical results seem encouraging even if the same aspect in literature is still too limited. Indeed, the management of Tendinopathy with the aid of oral supplementation is a relatively new approach.
Get In-Depth Knowledge on Tendinopathy Market Trends and Forecasts with DelveInsight @ Tendinopathy Market Drivers and Barriers [https://www.delveinsight.com/sample-request/tendinopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Tendinopathy Therapies and Companies
- NGI226: Novartis
- Emactuzumab: SynOx Therapeutics Limited
- ABSK021: Abbisko Therapeutics Co, Ltd
- AMB-05X: AmMax Bio, Inc.
- DCC-3014: Deciphera Pharmaceuticals LLC
- AIN457: Novartis
Tendinopathy Market Dynamics
The Tendinopathy market dynamics are anticipated to change in the coming years. Preclinical models have given credence to this emerging therapeutic modality, and compared to scaffolds and growth factors, there is a paucity of clinical studies using stem cells for augmentation of tendon repair or for treating Tendinopathy.
Unlock Strategic Insights with DelveInsight's Comprehensive Tendinopathy Market Report @ Tendinopathy Market Drivers and Barriers
Scope of the Tendinopathy Market Research Report
* Coverage- 7MM
* Study Period- 2020-2034
* Tendonitis Companies- MiMedex Group Inc, MEDRx USA Inc, Cerimon Pharmaceuticals, InGeneron Inc, ZetrOZ Inc, ZARS Pharma Inc, Smith & Nephew Inc ., and others.
* Tendonitis Pipeline Therapies- TENDAXION, TENDOFIT, ZEPTIDE, TENACTIVE/TENDOACTIVE, TENDOMAC, RITISAL, and others.
* Tendonitis Market Dynamics: Tendonitis Market Drivers and Barriers
* Tendonitis Market Access and Reimbursement, Unmet Needs, Analyst Views
Discover more about Tendinopathy Drugs in development @ Tendinopathy Ongoing Clinical Trials [https://www.delveinsight.com/sample-request/tendinopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
1. Key Insights
2. Tendonitis Executive Summary
3. Competitive Intelligence Analysis for Tendonitis
4. Tendonitis: Market Overview at a Glance
5. Tendonitis: Disease Background and Overview
6. Patient Journey
7. Tendonitis Epidemiology and Patient Population
8. Tendonitis Treatment Algorithm, Current Treatment, and Medical Practices
9. Tendonitis Unmet Needs
10. Key Endpoints of Tendonitis Treatment
11. Tendonitis Marketed Products
12. Tendonitis Emerging Therapies
13. Tendonitis: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Tendonitis Market Access and Reimbursement Overview
17. Tendonitis KOL Views
18. Tendonitis Market Drivers
19. Tendonitis Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=tendinopathy-market-size-in-the-7mm-is-project-to-grow-with-a-significant-cagr-by-2034-estimates-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/tendinopathy-market
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tendinopathy Market Size in the 7MM is Project to Grow with a Significant CAGR by 2034, estimates DelveInsight here
News-ID: 4345451 • Views: …
More Releases from ABNewswire
Bipolar Disorder Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Comp …
DelveInsight's "Bipolar Disorder Pipeline Insight 2026" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Bipolar Disorder pipeline landscape. It covers the Bipolar Disorder Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bipolar Disorder Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious about the latest updates…
Pre-Eclampsia Clinical Trial Pipeline Accelerates as 5+ Pharma Companies Rigorou …
DelveInsight's, "Pre-Eclampsia Pipeline Insight 2026" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Pre-Eclampsia pipeline landscape. It covers the Pre-Eclampsia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Pre-Eclampsia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious about the latest updates in the Pre-Eclampsia Pipeline? Click…
Nipocalimab Market Size Forecast and Emerging Insights Signal Strong Growth Outl …
Nipocalimab Overview in approved indications like Myasthenia gravis; as well as potential indications like Fetal erythroblastosis, Neonatal alloimmune thrombocytopenia, Sjogren's syndrome, Systemic lupus erythematosus and others.
The Nipocalimab market is entering a pivotal growth phase, driven by recent regulatory approvals, strong late-stage clinical data, expanding geographic reach, and a robust pipeline of potential label expansions across antibody-mediated diseases. As a next-generation neonatal Fc receptor (FcRn) blocker developed by Johnson & Johnson…
Myelofibrosis Market Expected to Surpass USD 5.3 Billion by 2034, estimates Delv …
The Myelofibrosis market across the seven major markets is projected to witness substantial expansion, growing from nearly USD 2,602 million in 2025 to about USD 5,638 million by 2034, registering a CAGR of around 9% over the forecast timeline.
In 2024, the overall Myelofibrosis market was valued at approximately USD 2.2 billion, with the United States accounting for the largest share at nearly USD 1.7 billion, significantly outperforming the EU4, the…
More Releases for Tendonitis
Tendonitis Treatment Market Future Prospects | • Johnson & Johnson • Pfizer
Worldwide Market Reports has added a new research study on "Tendonitis Treatment Market" is projected to experience substantial growth in the coming years. This report provides a comprehensive analysis of the market landscape using an integrated approach that includes research methodology, market size evaluation, data compilation, and insights gathered from multiple credible sources.
The study covers critical market elements such as market dynamics, drivers, restraints, challenges, threats, growth opportunities, development trends,…
Sports Injuries Fuel The Growth Of Tendonitis Treatment Market Emerges as a Core …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Tendonitis Treatment Market Through 2025?
The overall valuation of the tendonitis treatment market has experienced consistent expansion over the past few years. Projecting forward, this sector is slated to increase from its 2024 figure of $221.21 billion, reaching $228.07 billion by 2025,…
Tendonitis Market Size And Global Industry Forecast 2034
Introduction
Tendonitis, also known as tendinitis, refers to the inflammation or irritation of a tendon, the thick fibrous cords that attach muscle to bone. It is a common condition that can affect any tendon in the body, but it most often occurs in the shoulders, elbows, knees, and wrists. Tendonitis is typically caused by repetitive motion, overuse, or injury, and it can lead to significant pain, reduced mobility, and difficulty performing…
Prominent Tendonitis Treatment Market Trend for 2025: Advancements in Tendonitis …
What industry-specific factors are fueling the growth of the tendonitis treatment market?
The surge in sports injuries is projected to boost the tendonitis treatment market's expansion in the upcoming period. Sports injuries refer to any injury or damage incurred during sports or other physical activities, affecting the muscles, tendons, ligaments, bones, and joints. The treatment for tendonitis arising from sports injuries frequently involves a mix of rest, pain control, and physical…
Tendonitis Treatment Market Projected to Show Strong Growth
Global Tendonitis Treatment Market Report from Market Research Forecast highlights deep analysis on market characteristics, sizing, estimates and growth by segmentation, regional breakdowns & country along with competitive landscape, player's market shares, and strategies that are key in the market. The exploration provides a 360° view and insights, highlighting major outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions to…
Tendonitis Treatment Market Expecting Huge Demand in Upcoming Years
The latest Report Available at USD Analytics Market, "Tendonitis Treatment Market" provides a pin-point analysis of changing competitive dynamics and a forward-looking perspective on different factors driving or restraining industry growth.
As the Political, Economic, Social, Technological, Environmental, and Legal factors continue to change, business leaders across industries have shifted focus to strategic objectives to achieve market excellence. The "Global Tendonitis Treatment Market Size, Share Analysis with Forecast to 2030" report…
